# The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis

> **NCT00271310** · PHASE3 · COMPLETED · sponsor: **Royal Prince Alfred Hospital, Sydney, Australia** · enrollment: 164 (—)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** hypertonic saline

## Key facts

- **NCT ID:** NCT00271310
- **Lead sponsor:** Royal Prince Alfred Hospital, Sydney, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** —
- **Final completion:** 2003-11
- **Target enrollment:** 164 (—)
- **Last updated:** 2006-10-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271310, "The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00271310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
